Abbreviations
- ALK:
-
Anaplastic lymphoma kinase
- CMM:
-
Canine malignant melanoma
- CSPG4:
-
Chondroitin sulfate proteoglycan-4
- CSC:
-
Cancer stem cells
- DAA:
-
Disease-associated antigens
- ECT:
-
Electrochemotherapy
- EP:
-
Electro-permeabilization
- GVC:
-
Gene vaccination in cancer
- HPV:
-
Human papillomavirus
- MDSC:
-
Myeloid-derived suppressor cells
- MUC1:
-
Mucin1
- NHL:
-
Non-Hodgkin lymphoma
- NSCLC:
-
Non-small-cell lung cancer
- PBMC:
-
Peripheral blood mononuclear cells
- PD1:
-
Protectin D1
- PDA:
-
Pancreatic ductal adenocarcinoma
- TAA:
-
Tumor-associated antigens
- TERT:
-
Telomerase reverse transcriptase
Acknowledgments
This work was supported by grants from: Consorzio Universitario Piceno; Comune di Ascoli Piceno; Fondazione Cassa di Risparmio di Ascoli Piceno; Research Toxicology Centre (RTC); IGEA Clinical Biophysics; Transgene; Euroclone; Carlo Erba dasitgroup. The authors wish to thank the Italian Association for Cancer Research (IG 11675), Fondazione Ricerca Molinette Onlus, University of Torino, and Dale Lawson for his editing of the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bolli, E., Conti, L., Riccardo, F. et al. Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013. Cancer Immunol Immunother 63, 529–533 (2014). https://doi.org/10.1007/s00262-014-1526-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-014-1526-y